OT-717

N/A

Report date: 2025/01/26 17:32:08
NME

Base Information

Drug NameOT-717
Drug Alias Namecaspase 9 inhibitor (Columbia University/Sanford Burnham Prebys Medical Discovery Institute)OT-717
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-9 inhibitors
TargetsCaspase-9
Therapy Area/IndicationsRetinal Vein OcclusionRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesColumbia University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesColumbia University Medical CenterSanford Burnham Prebys Medical Discovery Institute
Inactive CompaniesN/A
Active IndicationsRetinal Vein OcclusionRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A